Skip to main content

2nd Annual Meeting LymphChip

november 1, 2023

On October 30-31 the second Annual Meeting of LymphChp was hosted by VUMC in Amsterdam.

In total 39 members of LymphChip attended the program representing the academic partners, co-financing partners and the Advisory Board.

The first day consisted of news updates on behalf of all the work packages. Most attendees joined for dinner that evening. On the second day invited lectures were given by representatives from industry and the Advisory Board followed by break-out sessions on topics selected on the spot and relating to technological and biological challenges. The newly designed chip, the design of which was drafted at one of the breakout sessions in the previous Annual Meeting attracted a lot of interest.

Representatives from the co-financing partners and the Advisory Board indicated that the meeting was very insightful and stimulated the young researchers to exploit the LymphChip network.

Meer nieuws

Workshop: Maskless Photolithography & Indentation
december 9, 2024
Dear LymphChip members, On January 21 the hands-on Workshop: Maskless Photolithography & Indentation organized by Alvéole, Optics11 Life and LUMC will be held at Sylviusweg 62 in Leiden, The Netherlands. A QR code to register for this workshop is presented in the attached flyer and below. Costs are 200 Euro (academic), 230 Euro (industry).
Midterm Self-evaluation LymphChip
november 25, 2024
Three NWA-ORC consortia: BioClock, LOSS and LymphChip met November 25 at the Lorentz Center in Leiden for a midterm self-evaluation to work towards societal impact. During the day best practices, challenges, needs and actions were discussed by young and senior researchers and by representatives from co-funding and cooperation partners.
Inaugural lecture Hans Bouwmeester LymphChip
november 22, 2024
On November 22, Hans Bouwmeester, PI in LymphChip presented his inaugural lecture entitled: “Is complexity always better? Connecting cells to systems in toxicology”. Within LymphChip, Hans Bouwmeester takes the lead in the development of an immunocompetent Intestine-on-chip model.